IGM Biosciences, Inc. (IGMS) DCF Valuation

IGM Biosciences, Inc. (IGMS) DCF Valuation
  • ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
  • ✓ Design Profissional: Modelos Confiáveis ​​E Padrão Da Indústria
  • ✓ Pré-Construídos Para Uso Rápido E Eficiente
  • ✓ Não É Necessária Experiência; Fácil De Seguir

IGM Biosciences, Inc. (IGMS) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Evaluate IGM Biosciences, Inc.'s financial outlook like an expert! This (IGMS) DCF Calculator provides pre-filled financial data along with full flexibility to modify revenue growth, WACC, margins, and other essential assumptions to align with your predictions.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 1.1 2.1 2.7 3.3 4.1 5.2 6.5
Revenue Growth, % 0 0 0 0 99.25 24.81 24.81 24.81 24.81 24.81
EBITDA -40.8 -77.8 -157.4 -221.9 -253.4 .5 .7 .8 1.0 1.3
EBITDA, % 100 100 100 -20755.94 -11894.74 20 20 20 20 20
Depreciation 2.3 3.6 7.7 10.6 8.3 2.7 3.3 4.1 5.2 6.5
Depreciation, % 100 100 100 991.77 388.59 100 100 100 100 100
EBIT -43.1 -81.4 -165.2 -232.5 -261.6 .5 .7 .8 1.0 1.3
EBIT, % 100 100 100 -21747.71 -12283.33 20 20 20 20 20
Total Cash 236.6 366.3 229.5 427.2 337.7 2.7 3.3 4.1 5.2 6.5
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 100 100 100 0 0
Inventories -12.0 .0 .0 .0 .0 1.6 2.0 2.5 3.1 3.9
Inventories, % 100 100 100 0 0 60 60 60 60 60
Accounts Payable 3.1 7.9 5.6 2.5 1.3 2.5 3.1 3.8 4.8 6.0
Accounts Payable, % 100 100 100 234.99 62.25 92.45 92.45 92.45 92.45 92.45
Capital Expenditure -2.3 -17.5 -13.2 -10.2 -12.4 -1.1 -1.3 -1.7 -2.1 -2.6
Capital Expenditure, % 100 100 100 -954.72 -581.27 -40 -40 -40 -40 -40
Tax Rate, % -0.2759 -0.2759 -0.2759 -0.2759 -0.2759 -0.2759 -0.2759 -0.2759 -0.2759 -0.2759
EBITAT -42.5 -80.3 -160.7 -225.3 -262.4 .5 .7 .8 1.0 1.3
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -27.5 -101.4 -168.5 -228.0 -267.6 .1 2.5 3.1 3.8 4.8
WACC, % 5.29 5.29 5.28 5.28 5.29 5.28 5.28 5.28 5.28 5.28
PV UFCF
SUM PV UFCF 11.7
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 5
Terminal Value 149
Present Terminal Value 115
Enterprise Value 127
Net Debt -72
Equity Value 199
Diluted Shares Outstanding, MM 52
Equity Value Per Share 3.80

What You Will Get

  • Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real IGMS financials.
  • Real-World Data: Historical data and forward-looking estimates (as indicated in the yellow cells).
  • Forecast Flexibility: Modify forecast assumptions such as revenue growth, EBITDA %, and WACC.
  • Automatic Calculations: Instantly observe the effect of your inputs on IGM Biosciences’ valuation.
  • Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
  • User-Friendly Design: Organized for clarity and ease of use, complete with step-by-step instructions.

Key Features

  • Comprehensive Data: IGM Biosciences’ historical financial statements and pre-filled projections.
  • Customizable Inputs: Adjust WACC, tax rates, revenue growth, and EBITDA margins to suit your analysis.
  • Real-Time Insights: Monitor IGM Biosciences’ intrinsic value recalculating instantly.
  • Interactive Visuals: Dashboard graphs showcase valuation outcomes and essential metrics.
  • Designed for Precision: A professional-grade tool for analysts, investors, and finance professionals.

How It Works

  1. Download the Template: Gain immediate access to the Excel-based IGM Biosciences (IGMS) DCF Calculator.
  2. Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and other key variables.
  3. Instant Calculations: The model automatically computes the intrinsic value of IGM Biosciences.
  4. Test Scenarios: Experiment with various assumptions to assess potential changes in valuation.
  5. Analyze and Decide: Leverage the results to inform your investment or financial evaluation.

Why Choose This Calculator for IGM Biosciences, Inc. (IGMS)?

  • User-Friendly Interface: Perfect for both newcomers and seasoned professionals.
  • Customizable Parameters: Adjust inputs easily to suit your financial analysis.
  • Real-Time Insights: Watch IGM Biosciences’ valuation update instantly as you change inputs.
  • Pre-Loaded Data: Comes with IGM Biosciences’ actual financial metrics for immediate evaluation.
  • Relied Upon by Experts: A go-to tool for investors and analysts making strategic choices.

Who Should Use This Product?

  • Investors: Accurately assess IGM Biosciences, Inc.'s (IGMS) fair value prior to making investment choices.
  • CFOs: Utilize a professional-grade DCF model for comprehensive financial reporting and analysis.
  • Consultants: Efficiently customize the template for client valuation reports.
  • Entrepreneurs: Acquire insights into the financial modeling practices of top biotech firms.
  • Educators: Employ it as a teaching resource to illustrate valuation techniques.

What the Template Contains

  • Comprehensive DCF Model: Editable template featuring detailed valuation calculations tailored for IGM Biosciences, Inc. (IGMS).
  • Real-World Data: IGM Biosciences' historical and projected financials preloaded for in-depth analysis.
  • Customizable Parameters: Modify WACC, growth rates, and tax assumptions to explore various scenarios.
  • Financial Statements: Complete annual and quarterly breakdowns to gain deeper insights into financial performance.
  • Key Ratios: Integrated analysis for profitability, efficiency, and leverage specific to IGM Biosciences, Inc. (IGMS).
  • Dashboard with Visual Outputs: Visual representations including charts and tables for clear, actionable results.

No products were found matching.